Wong, Li PingLee, Hai YenAlias, HaridahZimet, GregoryLiu, TongyuLin, YulanHu, Zhijian2024-06-182024-06-182024Wong LP, Lee HY, Alias H, et al. Cost-based COVID-19 vaccination and willingness to pay: A post-pandemic review. Hum Vaccin Immunother. 2024;20(1):2313860. doi:10.1080/21645515.2024.2313860https://hdl.handle.net/1805/41587The primary objective of this paper is to serve as a valuable resource for policymakers who are confronted with the evolving landscape of the coronavirus disease 2019 (COVID-19), considering both free and cost-based vaccination approaches. The potential consequences of shifting from free to cost-based vaccination are explored, encompassing its impact on global vaccine equity and prioritization, economic well-being, healthcare systems and delivery, public health policies, and vaccine distribution strategies. Examining past studies on willingness to pay for the initial COVID-19 vaccine dose and booster shots provides insights into how individuals value COVID-19 vaccinations and underscores the significance of addressing issues related to affordability. If COVID-19 vaccinations incur expenses, using effective communication strategies that emphasize the importance of vaccination and personal health benefits can increase willingness to pay. Making COVID-19 vaccines accessible through public health programs or health insurance can help alleviate financial barriers and increase vaccination rates.en-USAttribution-NonCommercial 4.0 InternationalCOVID-19Cost-based vaccinationWillingness to payArticle